Seed VC · Singapore, Singapore
4BIO Capital is a London-based investment firm founded in 2018, specializing in advanced therapies and biotechnology. The company focuses on funding and supporting early-stage and growth-stage companies developing innovative treatments in areas such as gene therapy, cell therapy, RNA-based drugs, and targeted therapies. 4BIO Capital manages several funds and collaborates with academic institutions, research organizations, and industry partners to accelerate the development of transformative medical solutions. The firm is recognized for its expertise in the life sciences sector and its commitment to advancing next-generation therapeutics.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers
Geography
UK, Europe, USA, APAC
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
4BIO Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks 4BIO Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
4Bio Capital
advanced therapies, life sciences, gene therapy
Family Office
Aeternum Management AS
life sciences, healthcare, medical devices
Seed VC
Apeiron Investment Group
longevity, healthcare, life sciences
Seed VC
Armira
mid-market manufacturing, tech, health
Family Office
EQT Foundation
deeptech, life sciences, climate tech
Family Office
Feldberg Capital
real estate, residential, industrial & logistics
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. 4BIO Capital is one of them, and we'll tell you exactly where they sit in your top 100.